Zevra Therapeutics, Inc. (ZVRA) SEC Filings — 2024

Filings

• Zevra Therapeutics Appoints New Officers, Reports Q3 Loss — 8-K · Dec 6, 2024
• Zevra Therapeutics Files 8-K: Reg FD, Other Events — 8-K · Nov 22, 2024
• Zevra Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
• Zevra Therapeutics Q3 2024 Update — 10-Q · Nov 13, 2024
• Zevra Therapeutics Files 8-K on Financials — 8-K · Nov 12, 2024
• Zevra Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Zevra Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Zevra Therapeutics Files 8-K Report — 8-K · Sep 20, 2024
• Zevra Therapeutics Q2 2024: Net Loss Widens — 10-Q · Aug 14, 2024
• Zevra Therapeutics Files 8-K on Financials — 8-K · Aug 13, 2024
• Zevra Therapeutics Files 8-K Report — 8-K · Aug 9, 2024
• Zevra Therapeutics Files 8-K on Financials — 8-K · Aug 8, 2024
• Zevra Therapeutics Files 8-K — 8-K · Aug 5, 2024
• Zevra Therapeutics Terminates Material Agreement — 8-K · Jul 12, 2024
• Zevra Therapeutics Files 8-K Report — 8-K · Jul 9, 2024
• Zevra Therapeutics Files 8-K Report — 8-K · Jun 3, 2024
• Zevra Therapeutics Holds Annual Stockholder Meeting — 8-K · May 13, 2024
• Zevra Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Zevra Therapeutics Files 8-K on Financials — 8-K · May 8, 2024
• Zevra Therapeutics Files Proxy Materials — DEFA14A · Apr 29, 2024
• Zevra Therapeutics Enters New Agreement, Terminates Old One — 8-K · Apr 10, 2024
• Zevra Therapeutics Files DEF 14A for FY2023 — DEF 14A · Apr 3, 2024
• Zevra Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
• Zevra Therapeutics Restates Financials Due to Internal Control Weakness — 8-K · Mar 28, 2024
• Zevra Therapeutics Files 8-K Report — 8-K · Mar 27, 2024
• Zevra Therapeutics Files 8-K — 8-K · Mar 5, 2024
• Zevra Therapeutics, Inc. Files 8-K — 8-K · Mar 4, 2024
• Zevra Therapeutics Amends Bylaws, Changes Fiscal Year — 8-K · Feb 28, 2024
• Zevra Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Zevra Therapeutics Amends 8-K Filing, Updates Event Date — 8-K/A · Feb 5, 2024
• BlackRock Discloses 5.0% Stake in ZEVRA THERAPEUTICS — SC 13G · Jan 29, 2024
• Zevra Therapeutics Updates Executive Compensation Arrangements — 8-K · Jan 23, 2024
• Zevra Therapeutics Confirms Nasdaq Listing for ZVRA Common Stock — 8-K · Jan 8, 2024